These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4171585)

  • 41. [Vasopressin].
    Murase T; Yoshida T
    Horumon To Rinsho; 1972 Oct; 20(10):805-7. PubMed ID: 4568945
    [No Abstract]   [Full Text] [Related]  

  • 42. [Idiopathic diabetes insipidus. Changes of thyroid function before and after treatment with ADH].
    Rubio Pérez P; Sánchez Sánchez ML; Durán Escribano A; Del Rio Vázquez A; Vázquez Salamanca E; Espinos Pérez D
    Rev Clin Esp; 1977 Sep; 146(6):345-8. PubMed ID: 594442
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Night sweats. A dominant symptom in diabetes insipidus.
    Raff SB; Gershberg H
    JAMA; 1975 Dec; 234(12):1252-3. PubMed ID: 1242752
    [No Abstract]   [Full Text] [Related]  

  • 46. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 47. Diabetes insipidus: a two year study with 8-lysine vasopressin.
    Goodman RD
    Curr Ther Res Clin Exp; 1966 Feb; 8(2):56-60. PubMed ID: 4955382
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical resistance to vasopressin. Detection of antibody by hemagglutination.
    Soler NG; Myers WL; Sode J; Wortsman J
    Arch Intern Med; 1979 Jun; 139(6):677-9. PubMed ID: 443972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The therapy of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (autor's transl)].
    Novotný P
    Cas Lek Cesk; 1973 Jul; 112(35):1083-4. PubMed ID: 4751289
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
    Kauli R; Laron Z
    Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
    [No Abstract]   [Full Text] [Related]  

  • 51. Vasopressin in the treatment of diabetes insipidus.
    Hartshorn J; Hartshorn E
    J Neurosci Nurs; 1988 Feb; 20(1):58-9. PubMed ID: 2963876
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical value of the combination of vasopressin and chlorpropamide in a patient with "refractory" diabetes insipidus.
    Radó JP; Szende L; Takó J; Góth E; Fövényi J
    Endokrinologie; 1972 Feb; 59(2):203-12. PubMed ID: 5036075
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chlorpropamide, tolbutamide and saluretics in the treatment of diabetes insipidus sensitive to vasopressin].
    García Torres JA; De la Revilla L; Rosales G; Gutiérrez J; Peña JF; Estella F
    Rev Clin Esp; 1970 Feb; 116(3):237-42. PubMed ID: 5426161
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 55. Diabetes insipidus responding to parenteral vasopressin and nasal application of a solution of posterior pituitary powder.
    Jo Kian Tjay
    Paediatr Indones; 1967; 7(3):126-30. PubMed ID: 5596312
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus].
    László C; János J; Ferenc L
    Orv Hetil; 1977 Jul; 118(28):1648-50. PubMed ID: 876650
    [No Abstract]   [Full Text] [Related]  

  • 57. Hereditary vasopressin-resistant diabetes insipidus in SWV mice.
    Virgo NS; Miller JR
    Can J Physiol Pharmacol; 1974 Oct; 52(5):995-1011. PubMed ID: 4426000
    [No Abstract]   [Full Text] [Related]  

  • 58. [Changes in water metabolism of rats with diabetes insipidus under treatment with clofibrate, with or without ADH].
    Dumas JC; Garigue J; Roux G
    C R Seances Soc Biol Fil; 1972 Nov; 166(2):460-4. PubMed ID: 4662022
    [No Abstract]   [Full Text] [Related]  

  • 59. [Plasma renin activity in vasopressin-sensitive diabetes insipidus and changes in the same produced by clofibrate, carbamazepine and exogenous ADH].
    Holgado Silva C; Inoriza Rueda B; Vega Vázquez JM; Páez Antúnes C; Aznar Martín A; Carranza Conde M; Sánchez Burgos R; Aznar Reig A
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):311-3. PubMed ID: 7027368
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of diabetes insipidus in neurosurgical patients.
    Shucart WA; Jackson I
    J Neurosurg; 1976 Jan; 44(1):65-71. PubMed ID: 1104777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.